TY - JOUR
T1 - Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma
AU - Cannon, Andrew
AU - Thompson, Christopher Michael
AU - Bhatia, Rakesh
AU - Armstrong, Katharine Anne
AU - Solheim, Joyce Christopher
AU - Kumar, Sushil
AU - Batra, Surinder Kumar
N1 - Publisher Copyright:
© 2021, Japanese Society of Gastroenterology.
PY - 2021/8
Y1 - 2021/8
N2 - Pancreatic fibrosis (PF) is an essential component of the pathobiology of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC). Activated pancreatic myofibroblasts (PMFs) are crucial for the deposition of the extracellular matrix, and fibrotic reaction in response to sustained signaling. Consequently, understanding of the molecular mechanisms of PMF activation is not only critical for understanding CP and PDAC biology but is also a fertile area of research for the development of novel therapeutic strategies for pancreatic pathologies. This review analyzes the key signaling events that drive PMF activation including, initiating signals from transforming growth factor-β1, platelet derived growth factor, as well as other microenvironmental cues, like hypoxia and extracellular matrix rigidity. Further, we discussed the intracellular signal events contributing to PMF activation, and crosstalk with different components of tumor microenvironment. Additionally, association of epidemiologically established risk factors for CP and PDAC, like alcohol intake, tobacco exposure, and metabolic factors with PMF activation, is discussed to comprehend the role of lifestyle factors on pancreatic pathologies. Overall, this analysis provides insight into the biology of PMF activation and highlights salient features of this process, which offer promising therapeutic targets.
AB - Pancreatic fibrosis (PF) is an essential component of the pathobiology of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC). Activated pancreatic myofibroblasts (PMFs) are crucial for the deposition of the extracellular matrix, and fibrotic reaction in response to sustained signaling. Consequently, understanding of the molecular mechanisms of PMF activation is not only critical for understanding CP and PDAC biology but is also a fertile area of research for the development of novel therapeutic strategies for pancreatic pathologies. This review analyzes the key signaling events that drive PMF activation including, initiating signals from transforming growth factor-β1, platelet derived growth factor, as well as other microenvironmental cues, like hypoxia and extracellular matrix rigidity. Further, we discussed the intracellular signal events contributing to PMF activation, and crosstalk with different components of tumor microenvironment. Additionally, association of epidemiologically established risk factors for CP and PDAC, like alcohol intake, tobacco exposure, and metabolic factors with PMF activation, is discussed to comprehend the role of lifestyle factors on pancreatic pathologies. Overall, this analysis provides insight into the biology of PMF activation and highlights salient features of this process, which offer promising therapeutic targets.
KW - Cell signaling
KW - Chronic pancreatitis
KW - Myofibroblast
KW - Pancreatic cancer
KW - Pancreatic fibrosis
UR - http://www.scopus.com/inward/record.url?scp=85110851336&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110851336&partnerID=8YFLogxK
U2 - 10.1007/s00535-021-01800-4
DO - 10.1007/s00535-021-01800-4
M3 - Review article
C2 - 34279724
AN - SCOPUS:85110851336
SN - 0944-1174
VL - 56
SP - 689
EP - 703
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 8
ER -